Literature DB >> 1841026

Microangiopathy in diabetes mellitus: I. Causes, prevention and treatment.

S J Chittenden1, S K Shami.   

Abstract

Microangiopathy is the major cause of death in Insulin Dependent Diabetes Mellitus. However, the pathogenesis of microangiopathy is still far from clear. This paper is a review of the literature on diabetic microangiopathy and discusses the current theories concerning its causes, prevention and treatment. The roles of abnormal glucose metabolism, protein glycosylation, genetic factors and puberty as well as the changes in vascular endothelium, capillary permeability and blood constituents, in the development of microangiopathy are discussed. The benefits of strict control of blood glucose concentrations are discussed along with the action of various pharmaceutical preparations such as aldose reductase inhibitors, hydroxyrutosides, pentoxifylline and free radical scavengers currently assessed in the prevention or treatment of diabetic microangiopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1841026

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  2 in total

1.  Morphofunctional studies of the glomerular wall in mice lacking entactin-1.

Authors:  Simon-Philippe Lebel; Yong Chen; Diane Gingras; Albert E Chung; Moise Bendayan
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

2.  The GSK-3β/Fyn/Nrf2 pathway in fibroblasts and wounds of type 2 diabetes: On the road to an evidence-based therapy of non-healing wounds.

Authors:  Milad S Bitar
Journal:  Adipocyte       Date:  2012-07-01       Impact factor: 4.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.